Kazuaki Taguchi Selected Research

4'-cyano-2'-deoxyguanosine

5/2021	Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease.
1/2020	Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats.
6/2018	Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuaki Taguchi Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 01/2018
10	Infections 06/2023 - 01/2020
10	Hemorrhagic Shock 01/2023 - 06/2009
10	Hemorrhage 01/2021 - 04/2011
8	Chronic Renal Insufficiency 10/2023 - 12/2012
7	Inflammation (Inflammations) 01/2024 - 09/2011
7	Clostridium Infections 10/2023 - 11/2018
6	Poisoning 10/2023 - 10/2021
6	Fibrosis (Cirrhosis) 10/2023 - 02/2011
6	Thrombocytopenia (Thrombopenia) 11/2022 - 01/2013
5	Acute Kidney Injury (Acute Renal Failure) 09/2023 - 01/2019
4	Renal Insufficiency (Renal Failure) 12/2022 - 07/2007
4	Wounds and Injuries (Trauma) 01/2020 - 02/2015
3	Atrophy 05/2024 - 01/2023
3	Sepsis (Septicemia) 01/2023 - 04/2011
3	Meningitis 08/2022 - 09/2021
3	Bacterial Meningitis 08/2022 - 09/2021
3	Hypoxia (Hypoxemia) 01/2022 - 10/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2018
3	Hypoalbuminemia 06/2021 - 12/2010
2	Cardiotoxicity 05/2024 - 01/2024
2	Muscular Atrophy (Muscle Atrophy) 04/2024 - 01/2023
2	Reperfusion Injury 01/2024 - 07/2014
2	Ischemia 01/2024 - 10/2015
2	Pneumonia (Pneumonitis) 07/2023 - 01/2022
2	Acidosis 01/2023 - 01/2022
2	Rhabdomyolysis 01/2022 - 01/2020
2	Invasive Candidiasis 11/2021 - 11/2020
2	Candidemia 07/2021 - 11/2020
2	Chronic Hepatitis B 01/2020 - 06/2018
2	Pain (Aches) 05/2019 - 12/2012
2	Pancreatitis 11/2018 - 01/2016
2	Hepatitis 11/2018 - 02/2015
2	Hypertension (High Blood Pressure) 01/2018 - 12/2009
2	Lung Injury 01/2016 - 09/2011
2	Fetal Hypoxia 10/2015 - 10/2012

Drug/Important Bio-Agent (IBA)

16	Carbon MonoxideIBA 05/2024 - 01/2013
13	Hemoglobins (Hemoglobin)IBA 06/2023 - 06/2009
11	AlbuminsIBA 05/2024 - 12/2010
10	Vancomycin FDA LinkGeneric 11/2023 - 11/2018
10	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2011
8	Human Serum Albumin FDA LinkGeneric 10/2023 - 12/2010
8	Liposomes (Liposome)IBA 12/2021 - 03/2011
6	AntidotesIBA 10/2023 - 10/2021
6	AntioxidantsIBA 09/2023 - 01/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2020
6	Oxygen (Dioxygen)IBA 01/2020 - 06/2009
5	Daptomycin FDA Link 01/2023 - 01/2020
5	Therapeutic UsesIBA 01/2022 - 08/2014
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020 - 01/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 01/2018
4	MethemoglobinIBA 10/2023 - 10/2021
4	Metronidazole (Metric)FDA LinkGeneric 07/2023 - 11/2018
4	Cyanides (Isocyanides)IBA 01/2023 - 10/2021
4	Linezolid (Zyvox)FDA Link 11/2022 - 01/2013
4	EchinocandinsIBA 01/2022 - 11/2020
4	CytokinesIBA 01/2016 - 08/2014
3	Messenger RNA (mRNA)IBA 04/2024 - 10/2015
3	tedizolidIBA 11/2023 - 01/2022
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2023 - 01/2022
3	IndicanIBA 10/2023 - 07/2007
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2023 - 10/2021
3	NucleosidesIBA 05/2021 - 06/2018
3	4'-cyano-2'-deoxyguanosineIBA 05/2021 - 06/2018
3	Fibrinogen (Factor I)FDA Link 09/2015 - 08/2013
3	Adenosine Diphosphate (ADP)IBA 09/2015 - 08/2013
3	Immunoglobulin M (IgM)IBA 09/2015 - 03/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015 - 07/2007
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2022
2	MyostatinIBA 04/2024 - 01/2023
2	EnzymesIBA 12/2023 - 08/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023 - 08/2014
2	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 01/2022
2	FidaxomicinIBA 05/2023 - 11/2022
2	AST 120IBA 01/2023 - 07/2007
2	Ceftazidime (Fortum)FDA LinkGeneric 12/2022 - 08/2022
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2022 - 12/2019
2	SuspensionsIBA 12/2021 - 01/2016
2	beta-Lactamases (beta-Lactamase)IBA 11/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2021 - 12/2019
2	PolyenesIBA 11/2020 - 11/2020
2	CytochromesIBA 10/2020 - 01/2013
2	Antiviral Agents (Antivirals)IBA 01/2020 - 06/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2019
2	SaltsIBA 12/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 05/2019
2	BenzbromaroneIBA 01/2018 - 01/2015
2	Heme (Haem)IBA 10/2015 - 07/2014

Therapy/Procedure

10	Therapeutics 05/2024 - 10/2012
10	Resuscitation 01/2023 - 06/2009
3	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024 - 01/2020
3	Ligation 01/2023 - 04/2011
2	Aftercare (After-Treatment) 10/2023 - 01/2022
2	Nephrectomy 10/2023 - 01/2023
2	Punctures 01/2023 - 04/2011
2	Renal Dialysis (Hemodialysis) 12/2022 - 01/2021
2	Oral Administration 05/2019 - 01/2018
2	Erythrocyte Transfusion 11/2015 - 01/2013
2	Injections 09/2015 - 03/2011